Person: OGAN, AYŞE
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Job Title
Last Name
OGAN
First Name
AYŞE
Name
5 results
Search Results
Now showing 1 - 5 of 5
Publication Metadata only Preparation and drug release properties of lignin-starch biodegradable films(WILEY-V C H VERLAG GMBH, 2012) OGAN, AYŞE; Calgeris, Ilker; Cakmakci, Emrah; Ogan, Ayse; Kahraman, M. Vezir; Kayaman-Apohan, NilhanStarch is one of the most commonly available natural polymers which are obtained from agro-sources. It is renewable and abundant in nature. Unfortunately due to its poor mechanical properties and hygroscopic nature, there are some strong limitations to the development of starch-based products. Usually blends of starch are prepared and plasticized with glycerol to improve some of its properties. In this study, lignin was extracted from hazelnut shells and investigated as a potential additive for starch biofilms. The structural characterization of hazelnut lignin was performed by employing UV spectroscopy and Fourier transform infrared (FTIR) spectroscopy. Lignin was blended with corn starch in different ratios to obtain biofilms. Mechanical and thermal properties of the biofilms were enhanced as the lignin amount was increased in the formulations. Water absorption tests were performed at pH 2.0, 4.0, and 6.0. The percent swelling values of the starch/lignin films increased as pH increased. Also, the biofilm exhibiting the best properties was chosen for the drug release studies. Biofilms showed a fast ciprofloxacin (CPF) release within an hour and then the drug release rate decreased. A pH dependent drug release mechanism was also observed according to KoshnerPeppas model. The drug release increased with a decrease in pH.Publication Open Access Immobilization of acetylcholinesterase onto pyrrole-containing photocured thermosets(2023-04-01) DEMİR, SERAP; ÇAKMAKÇI, EMRAH; OGAN, AYŞE; ALI K. K., DEMİR S., ÇAKMAKÇI E., OGAN A.Acetylcholinesterase (AChE; EC 3.1.1.7) is a group of enzymes that catalyzes the hydrolysis of the neurotransmitter acetylcholine (ACh) into choline and acetate. AChE inhibition is commonly utilized as a biomarker for pesticides. In membrane based AChE biosensors the enzyme immobilization onto an electrode surface is of prime importance. In previous studies, conducting polymers-based supports have been used for the immobilization of AChE. In this study, a novel immobilization platform was developed. The simultaneous polymerization of pyrrole and functional thiol/ene monomers was performed to prepare conductive thermosets. AchE was covalently immobilized onto the membranes through the epoxy functional groups. After the immobilization process, the optimal temperature increased to 50 °C, displaying a better thermal stability and the optimum pH was elevated to 8.5. The activity of the immobilized enzyme was tested in the presence of several metals, and it was found that Cu2+ ions caused a noticable inhibition. After 10 cycles, the immobilized enzyme retained 51% of its original activity. In accordance with our results; the durability and the stability of the immobilized enzyme were improved. In future studies, the method applied here can be used in the design of an AchE biosensor.Publication Metadata only Preparation, characterization, and in vitro evaluation of isoniazid and rifampicin-loaded archaeosomes(WILEY, 2018) OGAN, AYŞE; Attar, Azade; Bakir, Ceren; Yuce-Dursun, Basak; Demir, Serap; Cakmakci, Emrah; Danis, Ozkan; Birbir, Meral; Ogan, AyseThe ability of Archaea to adapt their membrane lipid compositions to extreme environments has brought in archaeosomes into consideration for the development of drug delivery systems overcoming the physical, biological blockades that the body exhibits against drug therapies. In this study, we prepared unilamellar archaeosomes, from the polar lipid fraction extracted from Haloarcula 2TK2 strain, and explored its potential as a drug delivery vehicle. Rifampicin and isoniazid which are conventional drugs in tuberculosis medication were loaded separately and together in the same archaeosome formulation for the benefits of the combined therapy. Particle size and zeta potential of archaeosomes were measured by photon correlation spectroscopy, and the morphology was assessed by with an atomic force microscope. Encapsulation efficiency and loading capacities of the drugs were determined, and in vitro drug releases were monitored spectrophotometrically. Our study demonstrates that rifampicin and isoniazid could be successfully loaded separately and together in archaeosomes with reasonable drug-loading and desired vesicle-specific characters. Both of the drugs had greater affinity for archaeosomes than a conventional liposome formulation. The results imply that archaeosomes prepared from extremely halophilic archaeon were compatible with the liposomes for the development of stable and sustained release of antituberculosis drugs.Publication Metadata only Amine functional magnetic nanoparticles via waterborne thiol-ene suspension photopolymerization for antibody immobilization(ELSEVIER SCIENCE BV, 2018) OGAN, AYŞE; Muhsir, Pelin; Cakmakci, Emrah; Demir, Serap; Ogan, AyseThe modification of magnetic nanoparticles (MNPs) via different routes for biomolecule binding is an attractive area of research. Waterborne thiol-ene suspension photopolymerization (TESP) can be a useful method for preparing functional MNPs. In this study, for the very first time waterborne TESP was performed in the presence of MNPs. Neat MNPs were coated and in situ functionalized with amine groups by using thiol-ene chemistry. Engrailed-2 (EN2) protein, a potential biomarker for various cancers such as prostate cancer, bladder cancer, breast cancer and ovarian cancer, is known to be a strong binder to a specific DNA sequence (50-TAATTA-30) to regulate transcription. Anti-EN2 antibodies were immobilized onto these MNPs by physical adsorption and covalent bonding methods, respectively. The amount of the physically immobilized antibodies (0.54 mg/g) were found to be lower than the loading of the covalently bonded antibodies (1.775 mg/g). The biomarker level in the artificial solutions prepared was determined by enzyme-linked immunosorbent assay. Coated MNPs were characterized by FTIR, TGA, SEM and STEM. After TESP, the average diameter of the neat magnetite nanoparticles increased from similar to 15 nm to similar to 32 nm.Publication Metadata only Preparation of poly(3-hydroxybutyrate-co-hydroxyvalerate) films from halophilic archaea and their potential use in drug delivery(SPRINGER JAPAN KK, 2015) OGAN, AYŞE; Danis, Ozkan; Ogan, Ayse; Tatlican, Pinar; Attar, Azade; Cakmakci, Emrah; Mertoglu, Bulent; Birbir, MeralHalophilic archaea offer a potential source for production of polyhydroxyalkanoates (PHAs). Hence, the experiments were carried out with five extremely halophilic archaeal isolates to determine the highest PHA-producing strain. PHA production of each isolates was separately examined in cheap carbon sources such as corn starch, sucrose, whey, apple, melon and tomato wastes. Corn starch was found to be a fairly effective substrate for PHA production. Among the strains studied here, the strain with the highest capability for PHA biosynthesis was found to be 1KYS1. Phylogenetic analysis based on 16S rRNA gene sequence comparison showed that 1KYS1 closely related to species of the genus Natrinema. The closest phylogenetic similarity was with the strain of Natrinema pallidum JCM 8980 (99 %). PHA content of 1KYS1 was about 53.14 % of the cell dry weight when starch was used as a carbon source. The formation of large and uniform PHA granules was confirmed by transmission electron microscopy and the biopolymer was identified as poly(3-hydroxybutyrate-co-hydroxyvalerate) (PHBV). PHBV produced by 1KYS1 was blended with low molar mass polyethylene glycol (PEG 300) to prepare biocompatible films for drug delivery. Rifampicin was used as a model drug and its release from PHBV films was investigated at pH 7.4, 37 A degrees C. It was found that PHBV films obtained from 1KYS1 were very effective for drug delivery. In conclusion, PHBV of 1KYS1 may have a potential usage in drug delivery applications.